4-Bromo-2-methoxyaniline, 98%, Thermo Scientific Chemicals
4-Bromo-2-methoxyaniline, 98%, Thermo Scientific Chemicals
4-Bromo-2-methoxyaniline, 98%, Thermo Scientific Chemicals
Thermo Scientific Chemicals

4-Bromo-2-methoxyaniline, 98%, Thermo Scientific Chemicals

Have Questions?
Catalog NumberQuantity
H61454.06
also known as H61454-06
5 g
Catalog number H61454.06
also known as H61454-06
Price (EUR)
78,40
Each
Quantity:
5 g
Request bulk or custom format
Price (EUR)
78,40
Each
Chemical Identifiers
CAS59557-91-4
IUPAC Name4-bromo-2-methoxyaniline
Molecular FormulaC7H8BrNO
InChI KeyWRFYIYOXJWKONR-UHFFFAOYSA-N
SMILESCOC1=C(N)C=CC(Br)=C1
View more
SpecificationsSpecification SheetSpecification Sheet
Assay (HPLC)>97.5%
4-Bromo-2-methoxyaniline is used as a reagent in the synthesis of 3,5-diamino-1,2,4-triazole ureas as potent anaplastic lymphoma kinase (ALK) inhibitors. It is also used as a reagent in the synthesis of chroman-3-amides as potent Rho kinase inhibitors. It is an important raw material and intermediate used in organic synthesis, pharmaceuticals, agrochemicals and dyestuff fields.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
4-Bromo-2-methoxyaniline is used as a reagent in the synthesis of 3,5-diamino-1,2,4-triazole ureas as potent anaplastic lymphoma kinase (ALK) inhibitors. It is also used as a reagent in the synthesis of chroman-3-amides as potent Rho kinase inhibitors. It is an important raw material and intermediate used in organic synthesis, pharmaceuticals, agrochemicals and dyestuff fields.

Solubility
Soluble in methanol.

Notes
Keep container tightly sealed. Store in cool, dry conditions in well sealed containers. Incompatible with oxidizing agents.
RUO – Research Use Only

General References:

  1. P. S. Portoghese.; H. Nagase.; A. W. Lipkowski.; D. L. Larson.; A. E. Takemori. Binaltorphimine-related bivalent ligands and their .kappa. opioid receptor antagonist selectivity [Erratum to document cited in CA108(17):150771q]. J. Med. Chem. 1988, 31 (10), 2056-2056.
  2. Kate M. Clapham.; Julia Bardos.; M. Raymond V. Finlay.; Bernard T. Golding.; Edward J. Griffen.; Roger J. Griffin.; Ian R. Hardcastle.; Keith A. Menear.; Attilla Ting.; Paul Turner.; Gail L. Young.; Celine Cano. DNA-dependent protein kinase (DNA-PK) inhibitors: Structure-activity relationships for O-alkoxyphenylchromen-4-one probes of the ATP-binding domain. Bioorganic & Medicinal Chemistry Letters. 2011, 21 (3), 966-970.